Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Progression of physical inactivity in COPD patients: the effect of time and climate conditions - a multicenter prospective cohort study.

Boutou AK, Raste Y, Demeyer H, Troosters T, Polkey MI, Vogiatzis I, Louvaris Z, Rabinovich RA, van der Molen T, Garcia-Aymerich J, Hopkinson NS.

Int J Chron Obstruct Pulmon Dis. 2019 Sep 3;14:1979-1992. doi: 10.2147/COPD.S208826. eCollection 2019.

2.

Community-based pulmonary rehabilitation during acute exacerbation of chronic obstructive pulmonary disease: Pilling up the evidence.

Boutou AK, Kontakiotis T.

Pulmonology. 2019 Sep 24. pii: S2531-0437(19)30136-9. doi: 10.1016/j.pulmoe.2019.07.005. [Epub ahead of print] No abstract available.

3.

Physical Activity in Patients with Sarcoidosis: The Role of Cardiac and Musculoskeletal Involvement.

Boutou AK.

Lung. 2019 Aug 28. doi: 10.1007/s00408-019-00266-9. [Epub ahead of print] No abstract available.

PMID:
31463550
4.

Bone mineral density and associated fractures in COPD patients: The role of inflammation and pulmonary rehabilitation.

Boutou AK, Papathanassiou M, Chloros A.

Respir Med. 2019 May 26. pii: S0954-6111(19)30174-X. doi: 10.1016/j.rmed.2019.05.015. [Epub ahead of print] No abstract available.

PMID:
31153675
5.

The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Piperidou A, Sarafidis P, Boutou A, Thomopoulos C, Loutradis C, Alexandrou ME, Tsapas A, Karagiannis A.

J Hypertens. 2019 Jul;37(7):1334-1343. doi: 10.1097/HJH.0000000000002050.

PMID:
31145707
6.

Exercise capacity in borderline mean pulmonary artery pressure: Is it all about peak VO2 ?

Boutou AK, Pitsiou G, Panagiotidou E, Stanopoulos I.

Clin Respir J. 2019 Jul;13(7):480-481. doi: 10.1111/crj.13033. Epub 2019 May 16. No abstract available.

PMID:
31054184
7.

Physical Inactivity and Sedentarism among COPD Patients: What About Dynamic Hyperinflation?

Boutou AK.

COPD. 2019 Feb;16(1):108. doi: 10.1080/15412555.2019.1594747. Epub 2019 May 2. No abstract available.

PMID:
31044625
8.

Noninvasive Ventilation to Treat Respiratory Failure After Cardiac Surgery: Predictors of Application and Outcome.

Ampatzidou F, Boutou AK, Karagounis L, Marczin N, Gogakos A, Drossos G.

Respir Care. 2019 Sep;64(9):1123-1131. doi: 10.4187/respcare.06062. Epub 2019 Apr 2.

PMID:
30940723
9.

The use of cardiopulmonary exercise testing in identifying the presence of obstructive sleep apnea syndrome in patients with compatible symptomatology.

Stavrou V, Boutou AK, Vavougios GD, Pastaka C, Gourgoulianis KI, Koutedakis Y, Daniil Z, Karetsi E.

Respir Physiol Neurobiol. 2019 Apr;262:26-31. doi: 10.1016/j.resp.2019.01.010. Epub 2019 Jan 23.

PMID:
30684645
10.

Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.

Drosos G, Ampatzidou F, Sarafidis P, Karaiskos T, Madesis A, Boutou AK.

Am J Nephrol. 2018;48(2):108-117. doi: 10.1159/000492182. Epub 2018 Aug 15.

PMID:
30110680
11.

Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.

Raptis V, Bakogiannis C, Loutradis C, Boutou AK, Sioulis A, Balaskas E, Zebekakis P, Sarafidis PA.

Kidney Blood Press Res. 2018;43(3):744-754. doi: 10.1159/000489911. Epub 2018 May 22.

12.

Central Venous Oxygen Saturation as a Predictor of a Successful Spontaneous Breathing Trial from Mechanical Ventilation: A Prospective, Nested Case-Control Study.

Georgakas I, Boutou AK, Pitsiou G, Kioumis I, Bitzani M, Matei K, Argyropoulou P, Stanopoulos I.

Open Respir Med J. 2018 Mar 26;12:11-20. doi: 10.2174/1874306401812010011. eCollection 2018.

13.

Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.

Raptis V, Bakogiannis C, Loutradis C, Boutou AK, Lampropoulou I, Intzevidou E, Sioulis A, Balaskas E, Sarafidis PA.

Am J Nephrol. 2018;47(4):231-238. doi: 10.1159/000488115. Epub 2018 Mar 29.

PMID:
29597186
14.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.

15.

Exercise-induced changes in QT interval are smaller in COPD patients and have no impact on mortality.

Boutou AK, Franks R, Mohan D, Mantziari L, Wong T, Hopkinson NS, Polkey MI.

Eur Respir J. 2017 Mar 15;49(3). pii: 1602394. doi: 10.1183/13993003.02394-2016. Print 2017 Mar. No abstract available.

16.

Diabetes mellitus does not affect the incidence of acute kidney injury after cardiac surgery; a nested case-control study.

Moschopoulou M, Ampatzidou FC, Loutradis C, Boutou A, Koutsogiannidis CP, Drosos GE, Sarafidis PA.

J Nephrol. 2016 Dec;29(6):835-845. Epub 2016 Feb 29.

PMID:
26924544
17.

Endobronchial ultrasound: morphological predictors of benign disease.

Gogia P, Insaf TZ, McNulty W, Boutou A, Nicholson AG, Zoumot Z, Shah PL.

ERJ Open Res. 2016 Jan 20;2(1). pii: 00053-2015. eCollection 2016 Jan.

18.

Phenotyping Exercise Limitation in Systemic Sclerosis: The Use of Cardiopulmonary Exercise Testing.

Boutou AK, Pitsiou GG, Siakka P, Dimitroulas T, Paspala A, Sourla E, Chavouzis N, Garyfallos A, Argyropoulou P, Stanopoulos I.

Respiration. 2016;91(2):115-23. doi: 10.1159/000442888. Epub 2016 Jan 6.

19.

Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.

Manika K, Chatzika K, Papaioannou M, Kontou P, Boutou A, Zarogoulidis K, Kioumis I.

Int J Tuberc Lung Dis. 2015 Nov;19(11):1383-7. doi: 10.5588/ijtld.14.0935.

PMID:
26467592
20.

The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction.

Boutou AK, Zoumot Z, Nair A, Davey C, Hansell DM, Jamurtas A, Polkey MI, Hopkinson NS.

COPD. 2015;12(6):598-605. doi: 10.3109/15412555.2015.1020149. Epub 2015 Sep 23.

21.

Non-anaemic iron deficiency in COPD: a potential therapeutic target?

Boutou AK, Polkey MI, Hopkinson NS.

Respirology. 2015 Oct;20(7):1004-5. doi: 10.1111/resp.12616. Epub 2015 Aug 26. No abstract available. Erratum in: Respirology. 2016 Jan;21(1):196.

22.

COPD staging with GOLD: the newer the better?

Boutou AK.

Lancet Respir Med. 2015 Jun;3(6):418-9. doi: 10.1016/S2213-2600(15)00190-3. Epub 2015 May 17. No abstract available.

PMID:
25995070
23.

Resting energy expenditure in OSAS: the impact of a single CPAP application.

Fekete K, Boutou AK, Pitsiou G, Chavouzis N, Pataka A, Athanasiou I, Ilonidis G, Kontakiotis T, Argyropoulou P, Kioumis I.

Sleep Breath. 2016 Mar;20(1):121-8. doi: 10.1007/s11325-015-1194-y. Epub 2015 May 14.

PMID:
25971739
24.

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD.

Boutou AK, Tanner RJ, Lord VM, Hogg L, Nolan J, Jefford H, Corner EJ, Falzon C, Lee C, Garrod R, Polkey MI, Hopkinson NS.

BMJ Open Respir Res. 2014 Nov 3;1(1):e000051. doi: 10.1136/bmjresp-2014-000051. eCollection 2014.

25.

Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology.

Boutou AK, Hopkinson NS, Polkey MI.

Clin Sci (Lond). 2015 Mar;128(5):283-95. doi: 10.1042/CS20140344. Review.

26.

A combined pulmonary function and emphysema score prognostic index for staging in Chronic Obstructive Pulmonary Disease.

Boutou AK, Nair A, Douraghi-Zadeh D, Sandhu R, Hansell DM, Wells AU, Polkey MI, Hopkinson NS.

PLoS One. 2014 Oct 24;9(10):e111109. doi: 10.1371/journal.pone.0111109. eCollection 2014.

27.

Chronic thromboembolic pulmonary hypertension: do not miss the chance for an early diagnosis.

Bagalas V, Paspala A, Sourla E, Akritidou S, Tsolakidou K, Boutou A, Pitsis AA, Manika K, Kioumis IP, Stanopoulos I, Pitsiou G.

Am J Case Rep. 2014 Sep 5;15:378-81. doi: 10.12659/AJCR.891014.

28.

Does a single Pseudomonas aeruginosa isolation predict COPD mortality?

Boutou AK, Raste Y, Reid J, Alshafi K, Polkey MI, Hopkinson NS.

Eur Respir J. 2014 Sep;44(3):794-7. doi: 10.1183/09031936.00023414. Epub 2014 Jul 17. No abstract available.

29.

Non-invasive markers of pulmonary hypertension in interstitial lung disease: is cardiopulmonary exercise testing the Holy Grail?

Boutou AK, Pitsiou GG, Argyropoulou P.

Respirology. 2014 Jul;19(5):621-2. doi: 10.1111/resp.12321. Epub 2014 May 15. No abstract available.

30.

Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis.

Zoumot Z, Boutou AK, Gill SS, van Zeller M, Hansell DM, Wells AU, Wilson R, Loebinger MR.

Respirology. 2014 Jul;19(5):714-22. doi: 10.1111/resp.12287. Epub 2014 Apr 1.

31.

Predictors of exacerbations in COPD patients: the role of anaemia.

Boutou AK, Hopkinson NS, Polkey MI.

Int J Clin Pract. 2014 Jan;68(1):139-40. doi: 10.1111/ijcp.12270. No abstract available.

PMID:
24341309
32.

Repeated episodes of respiratory failure due to bilateral vocal cord paralysis.

Paspala A, Sourla E, Boutou A, Zoglopitis F, Pataka A, Bagalas V, Stanopoulos I, Pitsiou G.

J Emerg Med. 2013 Nov;45(5):e145-8. doi: 10.1016/j.jemermed.2013.05.053. Epub 2013 Aug 26.

PMID:
23988139
33.

Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension.

Pitsiou G, Paspala A, Bagalas V, Boutou AK, Stanopoulos I.

Anaesth Intensive Care. 2013 Jul;41(4):554-6. No abstract available.

34.

Lung function indices for predicting mortality in COPD.

Boutou AK, Shrikrishna D, Tanner RJ, Smith C, Kelly JL, Ward SP, Polkey MI, Hopkinson NS.

Eur Respir J. 2013 Sep;42(3):616-25. doi: 10.1183/09031936.00146012. Epub 2013 Jan 24.

35.

A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.

Sourla E, Paspala A, Boutou A, Kontou P, Stanopoulos I, Pitsiou G.

Ther Adv Respir Dis. 2013 Apr;7(2):119-23. doi: 10.1177/1753465812468042. Epub 2012 Dec 12.

PMID:
23235992
36.

The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis: A Case Control Study.

Manika K, Pitsiou GG, Boutou AK, Tsaoussis V, Chavouzis N, Antoniou M, Fotoulaki M, Stanopoulos I, Kioumis I.

Pulm Med. 2012;2012:252345. doi: 10.1155/2012/252345. Epub 2012 Jul 29.

37.

Respiratory muscle fatigue following exercise in patients with interstitial lung disease.

Elia D, Kelly JL, Martolini D, Renzoni EA, Boutou AK, Chetta A, Polkey MI, Hopkinson NS.

Respiration. 2013;85(3):220-7. doi: 10.1159/000338787. Epub 2012 Jul 19.

38.

Lemierre's syndrome presenting to the ED: rapidly fatal sepsis caused by methicillin-susceptible Staphylococcus aureus Staphylococcus protein A type t044.

Pitsiou G, Kachrimanidou M, Papa A, Kioumis I, Paspala A, Boutou A, Vlachou S, Tsorlini E, Argyropoulou-Pataka P.

Am J Emerg Med. 2013 Jan;31(1):268.e5-7. doi: 10.1016/j.ajem.2012.04.028. Epub 2012 Jul 15.

PMID:
22795989
39.

Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor.

Boutou AK, Karrar S, Hopkinson NS, Polkey MI.

Respiration. 2013;85(2):126-31. doi: 10.1159/000338792. Epub 2012 Jul 4.

40.

Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia?

Pitsiou G, Bagalas V, Boutou A, Stanopoulos I, Argyropoulou-Pataka P.

Sleep Breath. 2013 May;17(2):447-8. doi: 10.1007/s11325-012-0716-0. Epub 2012 May 6. No abstract available.

PMID:
22562264
41.

Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study.

Boutou AK, Pitsiou GG, Stanopoulos I, Kontakiotis T, Kyriazis G, Argyropoulou P.

QJM. 2012 Jul;105(7):657-63. doi: 10.1093/qjmed/hcs024. Epub 2012 Feb 21.

PMID:
22355163
42.

Spirometry values in a Greek population: is there an appropriate reference equation?

Kontakiotis T, Boutou AK, Ioannidis D, Papakosta D, Argyropoulou P.

Respirology. 2011 Aug;16(6):947-52. doi: 10.1111/j.1440-1843.2011.02002.x.

PMID:
21624003
43.

Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses.

Boutou AK, Stanopoulos I, Pitsiou GG, Kontakiotis T, Kyriazis G, Sichletidis L, Argyropoulou P.

Respiration. 2011;82(3):237-45. doi: 10.1159/000326899. Epub 2011 May 11. Erratum in: Respiration. 2011;82(6):521.

44.

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, Kontou PK, Chavouzis N, Nakou C, Argyropoulou P, Wasserman K, Stanopoulos I.

Respirology. 2011 Apr;16(3):451-8. doi: 10.1111/j.1440-1843.2010.01909.x.

PMID:
21122030
45.

Resolution of nocturnal periodic breathing in pulmonary hypertension after optimal treatment.

Pitsiou GG, Boutou AK, Nakou C, Chavouzis N, Fekete K, Stanopoulos I, Argyropoulou P.

Ther Adv Respir Dis. 2010 Aug;4(4):249-51. doi: 10.1177/1753465810371336. No abstract available.

PMID:
20696820
46.

Diagnostic accuracy of the rapid shallow breathing index to predict a successful spontaneous breathing trial outcome in mechanically ventilated patients with chronic obstructive pulmonary disease.

Boutou AK, Abatzidou F, Tryfon S, Nakou C, Pitsiou G, Argyropoulou P, Stanopoulos I.

Heart Lung. 2011 Mar-Apr;40(2):105-10. doi: 10.1016/j.hrtlng.2010.02.002. Epub 2010 May 4.

PMID:
20561873
47.

The use of open source and Web2.0 in developing an integrated EHR and e-learning system for the Greek Smoking Cessation Network.

Konstantinidis ST, Konstantinidis E, Nikolaidou MM, Boutou AK, Havouzis N, Argyropoulou P, Bamidis PD.

Stud Health Technol Inform. 2009;150:354-8.

PMID:
19745330
48.

Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?

Pitsiou GG, Spyratos D, Kioumis I, Boutou AK, Nakou C, Stanopoulos I.

Ther Adv Respir Dis. 2009 Jun;3(3):99-101. doi: 10.1177/1753465809341650. Epub 2009 Jul 28.

PMID:
19638368
49.

Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?

Pitsiou GG, Chavouzis N, Nakou C, Boutou AK, Argyropoulou P, Stanopoulos I.

J Heart Lung Transplant. 2009 Jun;28(6):651-3. doi: 10.1016/j.healun.2009.03.009.

PMID:
19481029
50.

Exogenous lipoid pneumonia complicated with mycobacterium infection in a subject with Zenker diverticulum.

Boutou AK, Trigonis I, Pigadas A, Argyropoulou P, Stanopoulos I.

Ann Acad Med Singapore. 2009 Feb;38(2):177-8. No abstract available.

Supplemental Content

Loading ...
Support Center